Make your money go further for just 25p per day

Proteome Sciences (AIM:PRM) - leading the way in diagnosis and disease monitoring

06/10/2015 · Proteome Sciences PLC (PRM) 

Increased awareness of the factors associated with disease has been accompanied by research within proteomics. It has been recognised that observing changes in protein markers can be important for both diagnosis and disease monitoring, as well as for the development of novel therapeutics. We’re taking a glance at one pioneer, Proteome Sciences (AIM:PRM), whose work has shown some interesting progressions in recent months.

With a growing demand for personalised medicine, the proteomics market has taken off substantially over the past few years. The work by Proteome Sciences focuses specifically on Biomarkers, Biomarker Assays and Isobaric and Isotopic Reagents, alongside the offering of Biomarker Services. The company have successfully established an IP portfolio of biomarkers associated with a range of diseases, as well as a patented tagging technology ‘Tandem Mass Tag®’ (TMT®), which can assist in the measurement of…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Proteome Sciences PLC

Proteome Sciences (AIM:PRM) - leading the way in diagnosis and disease monitoring

06/10/2015 · Company Insights
Increased awareness of the factors associated with disease has been accompanied by research within proteomics. It…

More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP